DirectoryState:Vic
Melbourne, Victoria, Australia
The market name for Afamelanotide is now SCENESSE®. Its a small injectable implant which mimics the body's natural ability to activate the skin pigment melanin, therefore producing a natural tan without being in sunlight. Obvious cosmetic benefits aside, its now being trialled for the treatment of nonsegmental vitiligo, the most common form of vitiligo by affecting over 45 million i ...
Read More...
Melbourne, Victoria, Australia
Ropren is a strong and effective natural hepatoprotector. Clinical trials have demonstrated that Ropren can normalizes lipid metabolism, strengthens the immune system, prevents and treats neurodegenerative disorders, including Alzheimer's disease. On 30 September, 2008 Solagran announced that initial sales of Ropren® in countries outside Russia has commenced with prices realised a ...
Read More...
On March 31, 2011, Bionic Vision announced they have completed the microchip that will be the engine for their wide-view bionic eye. The microchip is only five square millimeters and will be the heart of the retinal implant, which stimulates the retinal cells to elicit vision. Its a significant advance in nerve stimulation technology. It has 98 precisely-controlled stimulation chann ...
Read More...
Level 39 55 Collins Street, Melbourne, Victoria, 3000, AUSTRALIA
Mesoblast's MPC technology can generate both new bone and new blood vessels, enabling greater bone regeneration. There will be no immune reaction and no donor site, so no chronic pain. Implantation of MPC at the site of poorly-healing fractures is likely to be more effective in less time, while eliminating other complications of bone grafting.
Melbourne, VIC, 3000, Australia
Since MPC produce the proteoglycan materials found in discs, Mesoblast envisages that the injection of MPC into a degenerated intervertebral disc will lead to replacement of the protoeglycan of cartilage. This approach, with its anticipated ease of application and lack of side-effects, should offer a relatively non-invasive and cost-effective therapy for patients with moderate or se ...
Read More...
Level 39 55 Collins Street, Melbourne, VIC, 3000, Australia
Mesoblast is targeting the knee arthroscopy market for chronic osteoarthritis and acute cartilage tears in the belief that arthroscopic injection of its MPC product will enable regeneration of both cushioning and surface cartilage to permanently relieve pain and restore joint stability and freedom of movement.
About - Terms of use - Privacy Policy
Upgrade Your Body (TM) is managed by Consolidated Computing Pty Ltd.